Phase I 3D Conformal Radiation Dose Escalation Study in Newly Diagnosed Glioblastoma: RTOG 9803

PURPOSE: Phase I trial to evaluate the feasibility and toxicity of dose escalated 3DCRT concurrent with chemotherapy in patients with primary supratentorial GBM. MATERIALS/METHODS: 209 patients were enrolled. All received 46 Gy in 2 Gy fractions to PTV(1), defined as GTV plus 1.8 cm. Subsequent boos...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tsien, Christina, Moughan, Jennifer, Michalski, Jeff M, Gilbert, Mark R., Purdy, James, Simpson, Joseph, Kresel, John J., Curran, Walter J., Diaz, A., Mehta, Minesh P.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2008
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2913423/
https://ncbi.nlm.nih.gov/pubmed/18723297
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2008.05.034
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares